//
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR
Online Quantitative Aortographic Assessment of Aortic Regurgitation After TAVR: Results of the OVAL Study
Ascending Aortic Length and Risk of Aortic Adverse Events: The Neglected Dimension
Temporal Trends in Transcatheter Aortic Valve Replacement in France: FRANCE 2 to FRANCE TAVI
Low Transvalvular Flow Rate Predicts Mortality in Patients With Low-Gradient Aortic Stenosis Following Aortic Valve Intervention
Timing of intervention in asymptomatic patients with valvular heart disease
The Year in Cardiovascular Medicine 2020: Valvular Heart Disease: Discussing the Year in Cardiovascular Medicine for 2020 in the field of valvular heart disease is Professor Helmut Baumgartner and Dr Javier Bermejo. Mark Nicholls reports
A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial